Literature DB >> 30974027

Hydroalcoholic extract from Baccharis dracunculifolia recovers the gastric ulcerated tissue, and p-coumaric acid is a pivotal bioactive compound to this action.

Philipe Costa1, Thaise Boeing1, Lincon Bordignon Somensi1, Benhur Judah Cury1, Vanessa Lopes Espíndola1, Tauani Caroline Santos França1, Marília Oliveira de Almeida2, Caroline Arruda2, Jairo Kenupp Bastos2, Luisa Mota da Silva1, Sérgio Faloni de Andrade1.   

Abstract

Baccharis dracunculifolia is a medicinal plant native to southeastern Brazil and is the main botanical source used by bees (Apis mellifera) in the manufacture of green propolis and display similar gastroprotective action and chemical profile. This article reports the healing gastric ulcer activity of the hydroethanolic extract of B. dracunculifolia (HEBD) in an acetic acid-induced ulcer model. In addition to the extract, the isolated compounds ferulic acid, p-coumaric acid, caffeic acid, baccharin, and aromadendrin-4'-O-methyl ether were also assayed. HEBD at a dose of 300 mg/kg reduced the ulcerated area by 49.4% after treatment for 7 days, twice a day. Histological analyses revealed that the margins and base of the ulcer obtained significant regeneration, and periodic acid Schiff base staining showed a 78.2% increase in the mucin levels. The action on the enzymatic antioxidant system demonstrated an increased activity of superoxide dismutase and glutathione-S-transferase, in addition to raising glutathione reduced levels and myeloperoxidase activity. HEBD did not show cytotoxicity in the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylterazole bromine test. In vitro, HEBD inhibited the H+ /K+ -ATPase enzyme and showed antioxidant activity in the 2,2 diphenyl-1-picryllydrazyl test. Regarding the isolated compounds, oral administration of p-coumaric acid (15 mg/kg) reduced the ulcerated area by 66.2%. The results suggest that HEBD recovers the gastric ulcerated tissue, raising mucus and antioxidant enzyme levels, and reducing the H+ /K+ -ATPase activity. In addition, the findings confirm that p-coumaric acid is a pivotal bioactive compound on the gastric healing effects elicited by HEBD.
© 2019 BioFactors, 45(3):479-489, 2019. © 2019 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  Baccharis dracunculifolia; H+/K+-ATPase; gastric healing; p-coumaric acid

Mesh:

Substances:

Year:  2019        PMID: 30974027     DOI: 10.1002/biof.1503

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  3 in total

1.  Gastric healing effect of p-coumaric acid isolated from Baccharis dracunculifolia DC on animal model.

Authors:  Thaise Boeing; Philipe Costa; Larissa Venzon; Mariane Meurer; Luisa Nathália Bolda Mariano; Tauani Caroline Santos França; Luana Gouveia; Anny Caroline de Bassi; Viviane Steimbach; Priscila de Souza; Marília Oliveira de Almeida; Caroline Arruda; Sérgio Faloni de Andrade; Jairo Kenupp Bastos; Luisa Mota da Silva
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-08-11       Impact factor: 3.000

2.  Baccharis dracunculifolia DC Hydroalcoholic Extract Improves Intestinal and Hippocampal Inflammation and Decreases Behavioral Changes of Colitis Mice.

Authors:  Tauani Caroline Santos França; Ana Julia Ribeiro; Luísa Natália Bolda Mariano; Ana Caroline Dos Santos; Larissa Venzon; Lincon Bordignon Somensi; Ruan Kaio Silva Nunes; Camila André Cazarin; Karen Luz Okubo; Helenita Priscila Poerner; Jairo Kneupp Bastos; Márcia Maria de Souza; Luísa Mota da Silva
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-07       Impact factor: 2.629

3.  The Evaluation of Healing Properties of Galium verum-Based Oral Gel in Aphthous Stomatitis in Rats.

Authors:  Miona Vuletic; Vladimir Jakovljevic; Suzana Zivanovic; Milos Papic; Mirjana Papic; Rasa Mladenovic; Vladimir Zivkovic; Ivan Srejovic; Jovana Jeremic; Marijana Andjic; Aleksandar Kocovic; Jasmina Sretenovic; Slobodanka Mitrovic; Biljana Božin; Nebojša Kladar; Sergey Bolevich; Jovana Bradic
Journal:  Molecules       Date:  2022-07-22       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.